Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma
Washington University in St. Louis · Alvin J. Siteman Cancer Center
Abstract
Regulatory T cells (T(reg)) that prevent autoimmune diseases by suppression of self-reactive T cells may also suppress the immune response against cancer. In mice, depletion of T(reg) by Ab therapy leads to more efficient tumor rejection. T(reg)-mediated suppression of antitumor immune responses may partly explain the poor clinical response to vaccine-based immunotherapy for human cancer. In this study, we measured the prevalence of T(reg) that coexpress CD4 and CD25 in the PBLs, tumor-infiltrating lymphocytes, and regional lymph node lymphocytes from 65 patients with either pancreas or breast cancer. In breast cancer patients (n = 35), pancreas cancer patients (n = 30), and normal donors (n = 35), the…
Citation impact
- FWCI
- 12.32
- Percentile
- 100%
- References
- 30
Authors
11- ULUdaya LiyanageCorresponding
Washington University in St. Louis, Alvin J. Siteman Cancer Center
- TTTodd T. Moore
Washington University in St. Louis, Alvin J. Siteman Cancer Center
- HJHong‐Gu Joo
Washington University in St. Louis, Alvin J. Siteman Cancer Center
- YTYoshiyuki Tanaka
Washington University in St. Louis, Alvin J. Siteman Cancer Center
- VMVirginia M. Herrmann
Washington University in St. Louis, Alvin J. Siteman Cancer Center
Topics & keywords
- Medicine
- Tumor microenvironment
- Immune system
- Breast cancer
- Pancreatic cancer
- CD8
- IL-2 receptor
- Pancreas
- Good health and well-being